ARTIDIS AG
Nanotechnology tool for cancer diagnosis and treatment
ARTIDIS AG is a clinical stage health-tech company founded in Basel, Switzerland, that has developed the first nanomechanical biomarker for cancer diagnosis and treatment optimization. ARTIDIS nanotechnology platform integrates different types of clinical data into the ARTIDISNet digital platform, allowing physicians to significantly shorten the current diagnostic process and bringing benefit to both the patient and the healthcare system. ARTIDIS enables professionals to design personalised cancer treatment plans tailored to the individual patient needs and desired outcomes.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
11.10.2024
Boardroom powerhouses of industry veterans propel startups toward growth (startupticker.ch)
23.02.2023
Support from seasoned global industry leaders (startupticker.ch)
21.11.2022
Vier Unternehmerinnen mit ersten POWHER Award ausgezeichnet (startupticker.ch)
28.12.2020
Artidis applies its technology to lung cancer (startupticker.ch)
22.06.2020
Good news for cancer patients (startupticker.ch)
No milestones
No Jobs
Videos
ARTIDIS video
TOP 100 Swiss Startup Award
The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.
ARTIDIS AG
Nanotechnology tool for cancer diagnosis and treatment
Website:
www.artidis.com/
Headquarter:
Basel
Foundation Date:
July 2014
Technology:
- Medtech
Sectors:
- Big Data
- Cloud
- Digital Health
- Diagnostics
- Machine Learning / AI
- Medtech
- Organ and Tissues
Support received
